We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
The authors of this review sought to identify every study where people with an abdominal injury were randomised to surgery or observation
We are seeking your views on what procedures should be in scope of the licensing scheme for non-surgical cosmetic procedures in England.
People and businesses are invited to share their views on how to make non-surgical cosmetic procedures safer as thousands complain of ‘botched’ procedures.
There are different regulations which apply to devices and equipment including hand gels and PPE (personal protective equipment)
Section (4A.01 - 4A.31) last updated October 2023.
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
Find out when it's possible to get zero-rated supplies on medical and research goods and services that have been funded by charities.
Documents, certificate, letters, and notes available from the British embassy and consulates in the USA.
How to use an N-of-1 study to evaluate your digital health product.
What you need to know before you can place a medical device on the Great Britain market with a UKCA mark.
How a manufacturer can apply for approval to supply a non-compliant medical device on humanitarian grounds.
Apply for an authorisation to manufacture extemporaneous preparations, autogenous vaccines, stem cell products or blood products for non-food animals.
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).